Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring

Journal of Heart and Lung Transplantation

Volumn 18, Issue 2, 1999, Pages 143-149

  Meiser, Bruno M ^a   Pfeiffer, Matthias ^a   Schmidt, Dorothe ^a   Reichenspurner, Hermann ^a   Ueberfuhr, Peter ^a   Paulus, Daniela ^a   Von Scheidt, Wolfgang ^a   Kreuzer, Eckart ^a   Seidel, Dietrich ^a   Reichart, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEROID THERAPY; SURVIVAL; VOMITING;

ADOLESCENT; ADULT; AGED; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; SURVIVAL RATE; TACROLIMUS;

EID: 0032947542     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00002-3     Document Type: Article

References (30)

1. Meiser B.M., Ueberfuhr P., Martin S., et al. Single center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant. 17:1998;782-788.
2. Ensley R.D., Bristow M.R., Olsen S.L., et al. The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients. Transplantation. 56:1993;75-82.
3. Kirklin J.K., Bourge R.C., Naftel D.C., et al. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443) initial clinical experience . J Heart Lung Transplant. 113:1994;444-450.
4. Taylor D.O., Ensley R.D., Olsen S.L., et al. Mycophenolate mofetil (RS-61443) preclinical, clinical, and three-year experience in heart transplantation . J Heart Lung Transplant. 13:1994;571-582.
5. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet. 345:1995;1321-1325.
6. Sollinger H.W. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation. 60:1995;225-232.
7. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation. 61:1996;1029-1037.
8. Billingham M.E., Cary N.R.B., Hammond M.E., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart Rejection Study Group . J Heart Transplant. 9:1990;587-592.
9. Hosenpud J.D., Novick R.J., Bennett L.E., et al. The Registry of the International Society for Heart and Lung Transplantation Thirteenth Official Report - 1996 . J Heart Lung Transplant. 15:1996;655-674.
10. Pham S.M., Kormos R.L., Hattler B.G., et al. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation intermediate-term results . J Thorac Cardiovasc Surg. 11:1996;764-772.
11. Pham S.M., Kormos R.L., Kawai A., et al. Tacrolimus (FK 506) in clinical cardiac transplantation a five-year experience . Transplant Proc. 28:1996;1002-1004.
12. Rinaldi M., Pelligrini C., Martinelli L., et al. FK506 effectiveness in reducing acute rejection after heart transplantation a prospective randomized study . J Heart Lung Transplant. 16:1997;1001-1010.
13. Keenan R.J., Konishi H., Kawai A., et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg. 60:1995;580-585.
14. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet. 344:1994;423-428.
15. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 331:1994;1110-1115.
16. Mayer A.D., Dmitrewski J., Squifflet J.P., et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection a report of the European Tacrolimus Multicenter Renal Study Group . Transplantation. 64:1997;436-443.
17. Pirsch J.D., Miller J., Deierhoi M.H., et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation. 63:1997;977-983.
18. Grant D. Current results of intestinal transplantation. Lancet. 347:1996;1801-1803.
19. Gruessner R.W.G., Sutherland D.E.R., Drangstveit M.B., et al. Use of FK506 in pancreas transplantation. Transpl Int. 9:(suppl. 1):1996;251S-257S.
20. Reichart B., Meiser B., Viganò M., et al. European multicentre tacrolimus (FK506) heart pilot study One year results . J Heart Lung Transplant. 17:1998;775-781.
21. Taylor D.O., Barr M.L., Radovancevic B., et al. A comparison of tacrolimus- and cyclosporine-based immunosuppression in cardiac transplantation. J Heart Lung Transplant. 16:1997;72.
22. Klupp J., Bechstein W.O., Platz K.P., et al. Mycophenolate mofetil added to immunosuppression after liver transplantation - first results. Transplant Int. 10:1997;223-228.
23. Vanrenterghem Y, Squifflet JP, Forsythe J, et al. Randomised trial to investigate the efficacy and safety of a tacrolimus-based regimen in combination with mycophenolate mofetil in kidney transplantation [abstract]. Proceedings of the International Conference on Immunosuppression: 1997 Dec 11-13: Orlando.
24. Stratta R.J. Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients a multi-center report . Transplant Proc. 29:1997;654-655.
25. Billingham M.E. Pathology of heart transplantation. Solez K., Racusen L.C., Billingham M.E. Solid organ transplant rejection: mechanisms, pathology, and diagnosis. 1996;137-159 Marcel Dekker Inc, New York.
26. Sollinger H.W., Deierhoi M.H., Belzer F.O., et al. RS-61443 - a Phase I clinical trial and pilot rescue study. Transplantation. 53:1992;428-432.
27. th Annual Meeting of the American Society of Transplant Physicians: 1997 May 10-14: Chicago.
28. Filler G., Ehrich J. Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration. Nephrol Dial Transplant. 12:1997;374-375.
29. Krumme B. Pharmacokinetic monitoring of mycophenolic acid in the early period after renal transplantation [abstract]. In: Seidel B, Reichart B, editors. Proceedings of an International Conference on Progress in Transplantation Medicine: Research, Laboratory Monitoring and Clinical Perspectives: 1997 Oct 22-24: Nice.
30. Shaw L.M., Nowak I. Mycophenolic acid measurement and relationship to pharmacologic effects . Ther Drug Monit. 17:1995;685-689.